期刊文献+

间断应用甲状旁腺激素对人骨髓基质干细胞的影响 被引量:2

Effect of intermittent treatment with parathyroid hormone on human bone marrow stromal stem cells
下载PDF
导出
摘要 背景:持续应用和间断应用甲状旁腺激素以及使用量的大小对骨的效应有很大差异。目的:观察不同剂量的甲状旁腺激素间断给药对人骨髓基质干细胞增殖和分化的影响。方法:体外培养人骨髓基质干细胞,分为空白对照组和甲状旁腺激素5,20及50nmo/L组,每天作用1h,MTT法检测人骨髓基质干细胞的增殖;碱性磷酸酶活性测定检测人骨髓基质干细胞向成骨细胞的分化。结果与结论:甲状旁腺激素50nmol/L每天作用1h可显著促进人骨髓基质干细胞的增殖,同时使碱性磷酸酶升高,均显著高于其他3组。结果证实50nmo/L甲状旁腺激素间断应用可以促进人骨髓基质干细胞的增殖和向成骨细胞的分化。 BACKGROUND: Continuous and intermittent application of parathyroid hormone at different doses can cause different effects on bone. OBJECTIVE: To observe the effect of intermittent treatment with different doses of parathyroid hormone on the proliferation and differentiation of human bone marrow stromal stem cells. METHODS: Human bone marrow stromal stem cells were cultured in vitro and divided into blank control group and 5, 20 and 50 nmo/L parathyroid hormone group, and the parathyroid hormone groups were treated for 1 hour per day. MTT and alkaline phosphatase activities were used to detect the proliferation and differentiation of human bone marrow stromal stem cells to osteoblasts. RESULTS AND CONCLUSION: 50 nmol/L of parathyroid hormone treated for 1 hour per day could greatly promote the proliferation of human bone marrow stromal stem cells and could increase the alkaline phosphatase activities, and the alkaline phosphatase activities in 50 nmo/L parathyroid hormone group were higher than other three groups. Intermittent treatment with 50 nmol/L parathyroid hormone can promote the proliferation and differentiation of human bone marrow stromal stem cells.
出处 《中国组织工程研究》 CAS CSCD 2012年第23期4209-4212,共4页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献28

  • 1Zhu W,Yang ML,Yang GY. Changes in Serum Runt-related Transcription Factor 2 Levels After a 6-months Treatment with Recombinant Human Parathyroid Hormone in Patients with Osteoporosis[J].Journal of Endocrinological Investigation,2011.
  • 2Kobayashi T. Hormones and osteoporosis update.Mechanisms of anabolic and catabolic effects of PTH on bone[J].Clin Calcium,2009,(07):911-918.
  • 3Kaji H,Sugimoto T. Cytokines in bone diseases.Bone anabolic action of PTH and role of cytokine[J].Clin Calcium,2010,(10):1555-1561.
  • 4Rubin MR,Cosman F,Lindsay R. The anabolic effect of parathyroid hormone[J].Osteoporosis International,2002.267-277.doi:10.1007/s001980200026.
  • 5Andreassen TT,Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects[J].Journal of Cranio-Maxillofacial Surgery,2004,(03):424-427.
  • 6Callaci JJ,Juknelis D,Patwardhan A. Alcohol treatment increases vertebral bone loss following ovariectomy:compensation by intermittent parathyroid hormone[J].Alcoholism:Clinical and Experimental Research,2006,(04):665-672.doi:10.1111/j.1530-0277.2006.00078.x.
  • 7Sabbieti MG,Agas D,Xiao L. Endogenous FGF-2 is critically important in PTH anabolic effects on bone[J].Journal of Cellular Physiology,2009,(01):143-151.doi:10.1002/jcp.21661.
  • 8Aslan D,Andersen MD,Gede LB. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans[J].Scandinavian Journal of Clinical and Laboratory Investigation,2011.
  • 9殷晓雪,陈仲强,郭昭庆,马庆军,党耕町.人骨髓间充质干细胞定向诱导分化为成骨细胞及其鉴定[J].中国修复重建外科杂志,2004,18(2):88-91. 被引量:58
  • 10Kaji H. Parathyroid and bone.Effects of parathyroid hormone on bone resorption and formation:differences between intermittent and continuous treatment[J].Clin Calcium,2007,(12):1836-1842.

二级参考文献25

  • 1Morley P,Whitfield JF,Willick GE.Parathyroid hormone:an anabolic treatment for osteoporosis.Curr Pharm Des,2001,7:671-687.
  • 2Debiais F.Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.Joint Bone Spine,2003,70:465-470.
  • 3Okazaki K,Jingushi S,Ikenoue T,et al.Expression of parathyroid hormone-related peptide and insulin-like growth factor Ⅰ during rat fracture healing.J Orthop Res,2003,21:511-520.
  • 4Wang YH,Liu YL,Kathy Buhl,et al.Comparison of the Action of Transient and Continuous PTH on Primary Osteoblast Cultures Expressing Differentiation Stage-Specific GFP.J Bone Miner Res,2005,20:5-14.
  • 5Hock JM,Krishnan V,Onyia JE,et al.Osteoblast apoptosis and bone turnover.J Bone Miner Res,2001,16:975-984.
  • 6Roger S,Rittmaster,Michael Bolognese,Mark P,Ettinger,et al.Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by Alendronate.J Clin Endocrinol Metab,2000(85):2129-2134.
  • 7Robert M,Neer,Claude D,Amaud,Jose R,Zanchetta,et al.Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postenopausal women with osteoporsis.N Engl J Med,2001,344:1434-1441.
  • 8Jiang Y,Zhao JJ,Mitlak BH,et al.Recombinant human parathyroid hormone (1-34)[teriparatide] improves both cortical and cancellous bone structure.J Bone Miner Res,2003,18:1932-1941.
  • 9Lindsay R,Scheele WH,Neer R,et al.Sustained vertebral fracture risk reduction after withdrawaI of teriparatide in postmenopausal women with osteoporosis.Arch Intern Med,2004,164:2024-2030.
  • 10Crans GG,Silverman SL,Genant HK,et at.Association of severe vertebral fractures with reduced quality of life:reduction in the incidence of severe vertebral fractures by teriparatide.Arthritis Rheum,2004,50:4028 -4034.

共引文献60

同被引文献40

引证文献2

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部